Edison invites you to the Stem Cell Meeting on the Mesa
Date: 07 Oct 2015
Venue: Estancia La Jolla Hotel & Spa
Edison would like to invite you to attend the 2015 Stem Cell Meeting on the Mesa, October 7-9 in La Jolla, CA. Join more than 700 attendees throughout the three-day programme, including all of the major companies in the gene therapy, cell therapy and tissue engineering space.
This year’s conference features 60+ company presentations, which will also be available for one-to-one partnering opportunities at the meeting. Register today to meet with - Abeona Therapeutics, Accurexa, Argos Therapeutics, Asterias Biotherapeutics, Athersys, Avalanche Biotech, BioCardia, BioLife Solutions, bluebird bio, BrainStorm Cell Therapeutics, Caladrius Biosciences, Capricor Therapeutics, Cellectis, Cell Therapy , Cellular Dynamics International, Celyad, Cesca Therapeutics, Cyfuse, Cynata Therapeutics, DiscGenics, Editas Medicine, Fate Therapeutics, Fibrocell Science, GenVec, Healios, HemoStemix, Histogenics, Inovio Pharmaceuticals, InVivo Therapeutics, jCyte, Juventas Therapeutics, Kiadis Pharma, MaxCyte, MEDIPOST America, Mesoblast, MiMedx, MolMed, Organovo, Orthocell, Osiris Therapeutics, Oxford BioMedica, Pluristem Therapeutics, Regenerative Patch Technologies, REGENXBIO, ReNeuron, RepliCel, Sangamo BioSciences, SCM Life Science, Stanford University, StemBioSys, StemCells, TaiwanBio, TC BioPharm, Terumo BCT, TiGenix, TissueGene, uniQure, Vericel, ViaCyte, Videregen, Voyager Therapeutics.
Access Edison's Events Online
Please join us for the Edison Charity Bike Ride 2017
Edison, the investment research and advisory company, is once again partnering with the UK’s largest event for private investors. Now in its 15th year, the annual Master Investor Show connects investors with the CEOs and founders of exhibiting companies.
Richard Windsor, Edison's technology analyst is hosting a live webinar at 9am (GMT) on Tuesday 14th March. The webinar will be recorded for Edison TV with material relevant for those with an interest in Artificial Intelligence and the wider market implicat